Amundi Simulations Plus, Inc. Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Amundi holds 932 shares of SLP stock, worth $32,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
932
Previous 932
-0.0%
Holding current value
$32,014
Previous $29,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SLP
# of Institutions
169Shares Held
16.1MCall Options Held
11.1KPut Options Held
7.3K-
Conestoga Capital Advisors, LLC2.61MShares$89.6 Million0.97% of portfolio
-
Black Rock Inc. New York, NY2.46MShares$84.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$39.4 Million0.0% of portfolio
-
State Street Corp Boston, MA721KShares$24.8 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX702KShares$24.1 Million1.27% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $697M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...